14 reports

Asthma Spacers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026 ##.

  • Asthma
  • Chronic Disease
  • APAC
  • World
  • Company Financials

##.

  • Asthma
  • Chronic Disease
  • Pathology
  • World
  • Forecast
  • NOV 14, 2017: HOSPITAL AWARDED $7.9M GRANT FOR PEDIATRIC ASTHMA CARE
  • SEP 28, 2017: NEURO-IMMUNE CROSSTALK IN ALLERGIC ASTHMA

Summary National Heart Lung and Blood Institute (NHLBI), a subsidiary of National Institutes of Health is a medical research institute that provides treatment for heart, lung, and blood diseases.The institute conducts research studies with patients who have diseases of heart and blood vessels, lungs, blood cells and bone...

  • Asthma
  • Cardiovascular Disease
  • Healthcare
  • Hospital
  • United States
  • asthma therapy.
  • Asthma - Drug Profiles

Asthma - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Asthma - Pipeline Review, H2 2018, provides an overview of the Asthma (Respiratory) pipeline landscape. Asthma is a chronic disease involving the airways in the lungs....

  • Asthma
  • Biotech
  • Pharmaceutical
  • Respiratory Disease
  • AstraZeneca PLC
  • ACUTE ASTHMA THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY TRIAL STATUS, 2018*
  • ACUTE ASTHMA THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018*

Acute Asthma Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Acute Asthma Global Clinical Trials Review, H2, 2018" provides an overview of Acute Asthma clinical trials scenario.This report provides top line data relating to the clinical trials on Acute Asthma. Report...

  • Asthma
  • Clinical Trial
  • World
  • Product Initiative
  • Merck & Co., Inc.
  • Emergency asthma passport for adults
  • Asthma site, now containing the Breathing Space awareness program for uncontrolled allergic asthma

Digital Landscape: Asthma Summary "Digital Landscape: Asthma", analyzes digital activities undertaken by pharma industry in support of therapies for asthma. - The report includes digital activities directed towards patients and/or HCPs. - The geographic scope of the report is the United States,...

  • Application
  • Asthma
  • Mobile Application
  • United States
  • AstraZeneca PLC
  • ASTHMA
  • ASTHMA

Chronic Respiratory Disease Drug Development Pipeline Review, 2018 Summary Asthma is a chronic disease involving the airways in the lungs. Symptoms include shortness of breath, chest tightness or pain, chronic coughing and trouble sleeping due to coughing or wheezing. The predisposing factors include...

  • Asthma
  • Therapy
  • United States
  • Product Initiative
  • AstraZeneca PLC
  • Feb 28, 2017: Respiri's Text and App Messaging for Better Asthma Care
  • Other Significant Developments Sep 10, 2018: Respiri appoints SRX Global to manufacture wheeze and asthma sensor

Summary Respiri Ltd (Respiri), formerly iSonea Ltd, is a medical technology company that develops non-invasive medical devices and mobile health applications to improve the management of chronic respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). The company’s proprietary applications,...

  • Asthma
  • Australia
  • United States
  • World
  • Company
  • 11/10/2017: BENRALIZUMAB RECEIVES POSITIVE EU CHMP OPINION FOR SEVERE, UNCONTROLLED EOSINOPHILIC ASTHMA
  • 11/14/2017: FASENRA (BENRALIZUMAB) RECEIVES US FDA APPROVAL FOR SEVERE EOSINOPHILIC ASTHMA

Summary Kyowa Hakko Kirin Co Ltd (Kyowa Hakko), a subsidiary of Kirin Holdings Company Limited, is a research and development (R&D) based biotechnology company.It focuses on the discovery, development, production and commercialization of pharmaceuticals and biotechnology products. The company offers drugs in the...

  • Asthma
  • Pharmaceutical
  • Japan
  • United States
  • Kyowa Hakko Kirin Co., Ltd.
  • ASTRAZENECA ENTERS INTO LICENSING AGREEMENT WITH SYNAIRGEN FOR SNG001
  • PARTNERSHIPS

Inhaled IFN-beta has been effective at accelerating a recovery of virus-induced losses in lung function in two Phase II asthma trials (one conducted by Synairgen and one conducted by AstraZeneca).

  • Asthma
  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Synairgen plc
  • Feb 28, 2017: Respiri's Text and App Messaging for Better Asthma Care
  • Respiri Ltd - Major Products and Services

Respiri Ltd (RSH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations.The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The...

  • Asthma
  • Healthcare
  • World
  • Company Financials
  • Clinical Trial profile. 33 Trial Title
  • Clinical Trial profile. 73 Trial Title

Wheezing Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Wheezing Global Clinical Trials Review, H2, 2018" provides an overview of Wheezing clinical trials scenario.This report provides top line data relating to the clinical trials on Wheezing. Report includes...

  • Asthma
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative
  • Product Description
  • DEBT OFFERING

Dr Stephens is regarded as one of Australia' s foremost experts in the field of ovarian cancer research.

  • Asthma
  • Australia
  • Company
  • M&A
  • Invion Limited

REGN##, an antibody to interleukin-## receptor (IL-##), entered Phase ## clinical development for the treatment of asthma in the first quarter of 2017.

  • Arthritis
  • Asthma
  • United States
  • Company Financials
  • Regeneron Pharmaceuticals, Inc.